down arrow

CSPC Innovation Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: FMCG
  • ISIN: CNE100003K04
CNY
30.98
0.04 (0.13%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
CSPC Innovation Pharmaceutical Co., Ltd.
Why is CSPC Innovation Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.76% and Operating profit at -212.16% over the last 5 years
2
The company has declared negative results for the last 6 consecutive quarters
  • NET PROFIT(HY) At CNY -3.33 MM has Grown at -102.43%
  • INTEREST(HY) At CNY 7.8 MM has Grown at 172.47%
  • ROCE(HY) Lowest at -2.26%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 21.21%, its profits have fallen by -235.6%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CSPC Innovation Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
CSPC Innovation Pharmaceutical Co., Ltd.
3.79%
0.09
58.23%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.76%
EBIT Growth (5y)
-212.16%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.54
Tax Ratio
17.28%
Dividend Payout Ratio
51.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.16%
ROE (avg)
8.09%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
16.80
EV to EBIT
-107.83
EV to EBITDA
-177.45
EV to Capital Employed
27.76
EV to Sales
29.95
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
-25.74%
ROE (Latest)
-14.00%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET PROFIT(Q)

At CNY 23.57 MM has Grown at 280.21%

NET SALES(Q)

Highest at CNY 570.25 MM

PRE-TAX PROFIT(Q)

At CNY -24.35 MM has Grown at 75.72%

-24What is not working for the Company
NET PROFIT(HY)

At CNY -3.33 MM has Grown at -102.43%

INTEREST(HY)

At CNY 7.8 MM has Grown at 172.47%

ROCE(HY)

Lowest at -2.26%

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.76%

RAW MATERIAL COST(Y)

Grown by 5.31% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.98%

Here's what is working for CSPC Innovation Pharmaceutical Co., Ltd.
Net Profit
At CNY 23.57 MM has Grown at 280.21%
over average net sales of the previous four periods of CNY -13.08 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales
Highest at CNY 570.25 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Sales
At CNY 570.25 MM has Grown at 20.2%
over average net sales of the previous four periods of CNY 474.42 MM
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit
At CNY -24.35 MM has Grown at 75.72%
over average net sales of the previous four periods of CNY -100.29 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Here's what is not working for CSPC Innovation Pharmaceutical Co., Ltd.
Interest
At CNY 7.8 MM has Grown at 172.47%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio
Lowest at 3.76% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 2.98%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 5.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."